# Lilly announced a partnership with chip-maker Nvidia in October to build what it called the industry’s most powerful supercomputer.

*biotech · news · 2026-05-03 · Livemint*

## Key points

- Lilly and Roche are building industry-leading supercomputers with Nvidia partnerships to accelerate AI drug discovery.
- Takeda's AI-discovered psoriasis pill has succeeded in trials and is being submitted for U.S. approval this year.
- AI's biggest pharma impact so far is in manufacturing and operations, not novel drug discovery breakthroughs.
- Lilly used machine learning 'digital twins' to significantly boost production of its weight loss drug tirzepatide.
- Analysts estimate AI could save U.S. pharma $90 billion over five years, raising per-share profits by up to 13%.

**Companies:** Nvidia, Eli Lilly, Roche, GSK, AstraZeneca, Merck, Recursion Pharmaceuticals, Takeda, Astellas
**Countries:** United States, Japan

[Read the full story on Livemint](https://www.livemint.com/companies/news/the-quest-to-use-ai-to-help-find-new-drugs-11777772984510.html)

---

Canonical: https://newsio.io/n/c38380b8-3897-4a35-a908-56da3d81322a/lilly-announced-a-partnership-with-chip-maker-nvidia-in-october-to-build-what-it
Summarized by Newsio from Livemint. https://newsio.io/how-it-works